Time to Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis and Its Predictors: A National, Multicenter, Retrospective Cohort

Tavares, Ruben; Pope, Janet; TREMBLAY, JEAN-LUC; THORNE, CARTER; P. BYKERK, VIVIAN; Lazovskis, Juris; L.N. BLOCKA, KENNETH; J. BELL, MARY; Lacaille, Diane; Hitchon, Carol; A. FITZGERALD, AVRIL; K. FIDLER, WESLEY; A.M. BOOKMAN, ARTHUR; M. HENDERSON, JAMES; P. MOSHER, DIANNE; E. SHOLTER, DALTON; Khraishi, Majed; Haraoui, Boulos; CHEN, HONG; LI, XIUYING; Laupacis, Andreas; Boire, Gilles; Tomlinson, George; Bombardier, Claire

doi:10.3899/jrheum.120100

Public

Time to Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis and Its Predictors: A National, Multicenter, Retrospective Cohort

Published in The Journal of Rheumatology • Aug 15, 2012

Authors:

Ruben Tavares

Janet Pope

JEAN-LUC TREMBLAY

Abstract

OBJECTIVE: To determine the proportion of patients with rheumatoid arthritis (RA) under rheumatologic care treated with disease-modifying antirheumatic drugs (DMARD) within 6 months from symptom onset and the components of time to treatment and its predictors. METHODS: A historical inception cohort ...

Subject

Medicine

Internal medicine

Rheumatology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!